On the eve of Good Friday after the market had closed on Thursday, small cap chip stock Advanced Micro Devices, Inc (NYSE: AMD) did something unusual after its latest earnings report: It did not sink after�its latest�earnings reports. I should�mention that we�previously had�an open position in Advanced Micro Devices in�our SmallCap Network Elite Opportunity (SCN EO) portfolio from last summer up until�late January when we locked in a small loss.�We got out�in part because�while we believe in the company�� potential over the long term, our SCN EO�is a�trading rather than a buy and hold portfolio plus AMD�� shares sank�yet again�after�the company�reported earnings ��a repeat of what happened after three�previous earnings reports. However, the latest earnings report appears to have sent most of the bears (and many of the bashers who just hate this stock) into hibernation when you consider the following good news:
Hot Shipping Companies To Invest In Right Now: Immunomedics Inc.(IMMU)
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe. The company?s products include epratuzumab, a Phase III clinical trail product for the treatment of systemic lupus erythematosus and non-Hodgkin?s lymphoma; Veltuzumab, a Phase I/II clinical study completed product for the treatment of patients with non-Hodgkin?s lymphoma, immune thrombocytopenic purpura, and chronic lymphocytic leukemia; Yttrium Y 90 Clivatuzumab tetraxetan, a humanized monoclonal antibody for pancreatic cancer that is in Phase Ib/II clinical trail; and Yttrium Y 90 epratuzumab tetraxetan, a Phase I/II clinical study product for patients with non-Hodgkin?s lymphoma. Its early phase clinical trial products comprise Milatuzumab, a transmembrane protein product for antibody-drug conjugate therapy. The com pany also develops Dock-and-Lock methodology for making fusion proteins and multifunctional antibodies, as well as a new method of delivering imaging and therapeutic agents selectively to disease, primarily different solid cancers. In addition, it markets and sells a diagnostic product, LeukoScan, which is used to treat infection and inflammation in bones for patients with suspected osteomyelitis, including patients with diabetic foot ulcers. Immunomedics, Inc. has a license and collaboration agreement with Nycomed GmbH to develop, manufacture, and commercialize veltuzumab in the subcutaneous formulation for the treatment of various non-cancer indications; and a partnership and cross-licensing agreement with Alexis Biotech Ltd., to develop vaccines against cancers that include melanoma and chronic lymphocytic leukemia, and infectious diseases, such as AIDS. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Immunomedics (NASDAQ: IMMU ) , a biopharmaceutical company researching monoclonal, antibody-based products to treat cancer and other autoimmune disorders, jumped as much as 15% after providing a clinical update on its antibody-drug conjugate programs.
- [By George Budwell]
Immunomedics (NASDAQ: IMMU ) develops monoclonal antibodies for the treatment of cancer, autoimmune disorders, and other life-threatening diseases. The company has six products in clinical trials for a variety of diseases. Shares of Immunomedics have fallen hard and fast since the company announced the termination of a licensing deal with Takeda Pharmaceutical over veltuzumab last month. Even positive clinical trial results for 90-Y clivatuzumab, a treatment for advanced pancreatic cancer, failed to slow the fall. And last week, the pace of the decline picked up to the tune of a 15% drop on heavy volume.
10 Best Long Term Stocks To Watch Right Now: Sterlite Industries(India)
Sterlite Industries (India) Limited operates as a non-ferrous metals and mining company in India and internationally. It engages in the smelting and processing of copper and production of copper byproducts. The company?s primary products consist of copper cathode and continuos cast rods, as well as by products comprise sulphuric acid, phosphoric acid, hydrofluoro silicic acid, gypsum, ferro sand, and slime. It also owns the Mt. Lyell copper mine at Tasmania in Australia, as well as owns various zinc assets, including Skorpion Zinc in Namibia; Black Mountain Mines in South Africa; and Lisheen Mines in Ireland. In addition, the company produces aluminum from its bauxite mines. Its aluminum products include aluminum ingots and wire rods; rolled products, such as coils and sheets; and vanadium sludge as a by-product. Further, the company smelts and produces lead and zinc, as well as produces and sells sulphuric acid to fertilizer manufacturers and other industries; and silver ingots primarily to industrial users. It operates three lead-zinc mines in the state of Rajasthan, northwest India. Additionally, it involves in power generations business. As of March 31, 2011, the company had a power generation capacity of 1,041 MW from its thermal power plants and wind power plants. The company was formerly known as Sterlite Cables Limited and changed its name to Sterlite Industries (India) Limited in 1986.The company was incorporated 1975 and is based in Mumbai, India. Sterlite Industries (India) Limited is a subsidiary of Vedanta Resources plc.
Advisors' Opinion:- [By Rajhkumar K Shaaw]
BNP Paribas Securities (Asia) Ltd., Macquarie Capital Securities (India) Pvt. and Ambit Capital Pvt. cut their Sensex targets as the Reserve Bank of India unexpectedly increased its benchmark interest rate to stem a record decline in the rupee and curb consumer prices in the world�� second-most populous nation. Strategists reduced their average profit estimate by 4.5 percent as higher borrowing costs threaten to worsen the slowest economic expansion since 2009.
- [By Sy Harding]
Those largest holdings include Taiwan Semiconductor, Petroloeo Brasileiro (Brazil), China Mobile, China Construction Bank, CNOOK (China Offshore Drilling), Gazprom OAO (Russia), America Movil (Mexico), Sasol Ltd. (South Africa), Hon Hai Precision (Taiwan), and Infosys (India).
10 Best Long Term Stocks To Watch Right Now: Whiting USA Trust I(WHX)
Whiting USA Trust I is a REIT. The trust was founded in 2007 and is based in Austin, Texas.
Advisors' Opinion:- [By Roberto Pedone]
Another name that's starting to move within range of triggering a big breakout trade is Whiting USA Trust I (WHX). This stock hasn't done much so far in 2013, with shares up just 4.5%.
If you look at the chart for Whiting USA Trust I, you'll notice that this stock has been uptrending strong for the last few weeks, with shares moving higher from its low of $3.65 to its intraday high of $4.87 a share. During that move, shares of WHX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now spiked shares of WHX back above both its 50-day and 200-day moving averages, which is bullish. Shares of WHX are now quickly moving within range of triggering a big breakout trade.
Traders should now look for long-biased trades in WHX if it manages to break out above some near-term overhead resistance levels at $4.90 to $5.04 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 321,220 shares. If that breakout triggers soon, then WHX will set up to re-test or possibly take out its next major overhead resistance levels at $6.23 to $8.01 a share.
Traders can look to buy WHX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $4.12 a share. One can also buy WHX off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
10 Best Long Term Stocks To Watch Right Now: Imagination Technologies Group PLC (IGNMF.PK)
Imagination Technologies Group plc is engaged in multimedia and communication technologies. The Company operates in two segments: Technology business and the Pure business. The Company�� Technology business segment is engaged in the development of embedded graphics, video, display and multi-threaded processor and multi-standard broadcast receiver and connectivity technologies for licensing to semiconductor companies for incorporation into silicon devices. The Company�� Pure business segment is engaged in the development and marketing of consumer products to showcase the technologies of the Technology business and to develop markets for such technologies. In March 2012, Toumaz Ltd completed the exchange of Imagination Technologies Group plc's interest in Toumaz Ltd�� Toumaz Microsystems subsidiary. In February 2013, it acquired the operating business and certain patent properties of MIPS Technologies, Inc. Advisors' Opinion:- [By Ashraf Eassa]
However, I expect that Intel is at risk of having a significant marketing problem trying to sell a dual core product into a world of quad core phones, even if the dual core part delivers better performance/watt. I further expect that from what is currently known about Bay Trail's GPU (4 EU Gen7 GPU), it is unlikely that -- unless Intel is either using Imagination's (IGNMF.PK) next generation PowerVR 6 or a beefed up Gen7 design for the "Merrifield" SoC -- it will be as competitive with the Snapdragon 800 on the GPU side of things, which could pose as an additional headwind to adoption. I also believe that the Q1 2014 launch curtails any hope that there will be a 14nm smartphone product launched in 2014 (although Mr. Krzanich's comments about "acceleration" could be a source of optimism here), which means that the company's process lead could ultimately prove to be ephemeral in this particular end market. Fortunately, product cycles in this space are short, so it may be okay to have Merrifield be reasonably short lived.
10 Best Long Term Stocks To Watch Right Now: OncoGenex Pharmaceuticals Inc.(OGXI)
OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. The company?s clinical stage products include Custirsen, a phase III clinical stage product for treatment in men with metastatic castrate-resistant prostate cancer; OGX-427, which is in phase II clinical development stage is designed to inhibit heat shock protein 27; and SN2310 that completed phase I stage of clinical development is designed to evaluate safety in patients with advanced cancer. Its pre clinical stage products include GX-225 that is focused on reducing the production of IGFBP-2 and IGFBP-5; and CSP-9222, lead compound from a family of caspase activators. OncoGenex Pharmaceuticals, Inc. is based in Bothell, Washington.
Advisors' Opinion:- [By Lauren Pollock var popups = dojo.query(".socialByline .popC"); popups.forEach]
Teva Pharmaceutical Industries Ltd.(TEVA) and OncoGenex Pharmaceuticals Inc.(OGXI) said their experimental drug for hard-to-treat cases of prostate cancer didn’t result in statistically significant improvement in overall survival in a Phase 3 study. OncoGenex shares dropped 48% to $5 premarket.
10 Best Long Term Stocks To Watch Right Now: Weingarten Realty Investors(WRI)
Weingarten Realty Investors operates as a real estate investment trust (REIT). The company engages in the management, acquisition, and development of real estate. It operates in two segments, Shopping Center and Industrial. The Shopping Center segment engages in the acquisition, development, and management of real estate, primarily anchored neighborhood and community shopping centers located in Texas, California, Louisiana, Arizona, Nevada, Arkansas, New Mexico, Oklahoma, Tennessee, Kansas, Colorado, Missouri, Illinois, Florida, North Carolina, Mississippi, Georgia, Utah, Kentucky, and Maine. Its customer base includes supermarkets, discount retailers, drugstores, and other retailers. The Industrial segment engages in the acquisition, development, and management of bulk warehouses and office/service centers. Its properties are located in Texas, Nevada, Georgia, Florida, California, and Tennessee. As of June 30, 2005, Weingarten Realty Investors owned or operated under long -term leases, directly or through its interest in joint ventures or partnerships, a total of 350 developed properties and 3 properties that are in various stages of development. Its properties include 294 shopping centers and 59 industrial properties. Weingarten Realty Investors qualifies as a REIT for federal income tax purposes. As a REIT, it would not be taxed on the portion of its income, which is distributed to shareholders, provided it distributes at least 90% of its taxable income. The company was founded in 1948 and is based in Houston, Texas.
Advisors' Opinion:- [By Marc Bastow]
Shopping center real estate investment trust (REIT) Weingarten Realty (WRI) raised its quarterly dividend 6.6% to 32.5 cents per share, payable March 14 to shareholders of record as of March 6.
WGI Dividend Yield: 4.32%
10 Best Long Term Stocks To Watch Right Now: CyberOptics Corporation (CYBE)
CyberOptics Corporation supplies optical process control sensors and inspection systems to control the manufacturing process and ensure the quality of electronic circuit boards worldwide. The company also manufactures and sells sensors that assist with yield enhancement during semiconductor fabrication. Its products include surface mount technology (SMT) electronic assembly alignment sensors, including LaserAlign sensor that is incorporated into component placement machines used in the SMT production lines; BoardAlign camera, which identifies fiducial markings on a circuit board and aligns the board in the component placement machine prior to component placement; and InPrinter inspection camera that identifies fiducial markings on a circuit board to ensure accurate board registration prior to placement of solder paste. The company also offers photovoltaic and fuel cell alignment sensors, such as solar wafer alignment cameras for alignment measurements; and embedded process verification inspection technology products and solder paste inspection sensors. In addition, it provides SMT stand-alone inspection system products, which include solder paste inspection and automated optical inspection products; and WaferSense sensors that provide measurements of critical factors in the semiconductor fabrication process, as well as wafer mapping and alignment sensors, frame grabber products, and machine vision subsystems. The company sells its products to the manufacturers of electronic circuit board assembly equipment, manufacturers of semiconductor DRAM memory, and semiconductor capital equipment manufacturers, as well as end-user electronic assembly manufacturers, including original design manufacturers and electronic manufacturing service providers. CyberOptics Corporation markets its products through independent representatives and distributors. The company was founded in 1984 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By John Emerson]
I even recorded a tax loss carry-forward on my original purchase of CAMT for which I had paid $2.05 per share. It seems that I was a slow learner in regard to the necessity of selling AOI companies long before they entered a cyclical trough in their earnings. Happily, I have since remedied that problem. For informational purposes I must disclose that in the spring, I repurchased shares of CAMT and made a larger purchase in a Cyberoptics (CYBE) another AOI company, which was near a multiyear low at the time.
No comments:
Post a Comment